These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 14465012)

  • 1. [The content of M-substance as one of the indices of the virulence of streptococci of A group isolated during some streptococcal infections].
    LIAMPERT IM; VVEDENSKAIA OI
    Zh Mikrobiol Epidemiol Immunobiol; 1961 Aug; 32():43-8. PubMed ID: 14465012
    [No Abstract]   [Full Text] [Related]  

  • 2. Occurrence of the M. substance of type 28 group A in streptococci of Lancefield groups B, C and G.
    MAXTED WR
    J Gen Microbiol; 1949 Jan; 3(1):1-6. PubMed ID: 18126502
    [No Abstract]   [Full Text] [Related]  

  • 3. [The cell wall proteins of streptococci as factors in their pathogenicity].
    Shmakova ZF; Dmitrieva NF; Briko NI
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (3):113-8. PubMed ID: 8067081
    [No Abstract]   [Full Text] [Related]  

  • 4. Population and Whole Genome Sequence Based Characterization of Invasive Group A Streptococci Recovered in the United States during 2015.
    Chochua S; Metcalf BJ; Li Z; Rivers J; Mathis S; Jackson D; Gertz RE; Srinivasan V; Lynfield R; Van Beneden C; McGee L; Beall B
    mBio; 2017 Sep; 8(5):. PubMed ID: 28928212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on streptococci. IV. A study of the relationship of certain virulence factors in streptococcal infections to the LD 50 dose of streptococci.
    SHERWOOD NP; RUSSELL B; BOWMAN K; OTT J
    J Infect Dis; 1952; 91(3):246-59. PubMed ID: 13011397
    [No Abstract]   [Full Text] [Related]  

  • 6. Variation occurring in group A streptococci during human infection; progressive loss of M substance correlated with increasing susceptibility to bacteriostasis.
    ROTHBARD S; WATSON RF
    J Exp Med; 1948 Jun; 87(6):521-33. PubMed ID: 18858642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the question of the virulence of haemolytic streptococci.
    RASKA K; BEDNAR B; ROTTA J; JELINEK J; MOTTL J
    J Hyg Epidemiol Microbiol Immunol; 1959; 3():357-64. PubMed ID: 14436341
    [No Abstract]   [Full Text] [Related]  

  • 8. The behaviour of streptococci of varying virulence towards glutamine.
    HALE JH; McLLWAIN H
    Br J Exp Pathol; 1947 Oct; 28(5):346-51. PubMed ID: 20271613
    [No Abstract]   [Full Text] [Related]  

  • 9. Group A streptococcal infections of the skin: molecular advances but limited therapeutic progress.
    Currie BJ
    Curr Opin Infect Dis; 2006 Apr; 19(2):132-8. PubMed ID: 16514337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of hyaluronidase and type-specific anti-M serum on experimental group A streptococcus infection in mice.
    ROTHBARD S
    J Exp Med; 1948 Sep; 88(3):325-42. PubMed ID: 18881491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing pattern of neonatal streptococcal septicemia.
    Spigelblatt L; Saintonge J; Chicoine R; Laverdière M
    Pediatr Infect Dis; 1985; 4(1):56-8. PubMed ID: 3881743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virulence of group A streptococci for mice in relation to the production and destruction of hyaluronic acid.
    PIKE RM
    J Infect Dis; 1948; 83(1):19-22. PubMed ID: 18869803
    [No Abstract]   [Full Text] [Related]  

  • 13. [A study of M-substance in cultures of streptococci isolated during the course of various streptococcal diseases in different cities of the USSR].
    Khatenever ML; Iakhnina NA; Ugriumova GA; Zarubina KV; Chistenkov NA; Zakhar'evskaia NS; Gres' BE; Babeshkin NA; Dzhulgakova RS
    Zh Mikrobiol Epidemiol Immunobiol; 1969; 46(6):62-6. PubMed ID: 5346277
    [No Abstract]   [Full Text] [Related]  

  • 14. [Virulence determinations of the streptococcal strain Aronson in the white mouse].
    AUFFARTH F
    Dtsch Med Wochenschr; 1946 Dec; 71(29-32):319-21. PubMed ID: 20250137
    [No Abstract]   [Full Text] [Related]  

  • 15. The reemergence of serious group A streptococcal infections and acute rheumatic fever.
    Bronze MS; Dale JB
    Am J Med Sci; 1996 Jan; 311(1):41-54. PubMed ID: 8571986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to become a killer, or is it all accidental? Virulence strategies in oral streptococci.
    Sitkiewicz I
    Mol Oral Microbiol; 2018 Feb; 33(1):1-12. PubMed ID: 28727895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathogenicity for mice of group B streptococci of bovine origin.
    PATTISON IH
    J Hyg (Lond); 1949 Jun; 47(2):159-65, 2 pl. PubMed ID: 15392615
    [No Abstract]   [Full Text] [Related]  

  • 18. Suilysin production by Streptococcus suis strains isolated from diseased and healthy carrier pigs in Spain.
    Tarradas C; Borge C; Arenas A; Maldonado A; Astorga R; Miranda A; Luque I
    Vet Rec; 2001 Feb; 148(6):183-4. PubMed ID: 11258725
    [No Abstract]   [Full Text] [Related]  

  • 19. Susceptibility of chicken embryos to group A streptococci: correlation with fibrinogen binding.
    Schmidt KH; Wiesner J; Gerlach D; Reichardt W; Ozegowski JH; Köhler W
    FEMS Immunol Med Microbiol; 1993 Oct; 7(3):231-40. PubMed ID: 8275054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lipoteichoic and teichoic acids of pathogenic streptococci: structure, functions, and role in interaction of the infectious agent with organism].
    Dmitrieva NF; Timofeev IuM; Briko NI
    Zh Mikrobiol Epidemiol Immunobiol; 2007; (6):100-7. PubMed ID: 18277547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.